Advisers do well in bull markets and poorly in bear markets, while I generally do better during downturns than the S&P 500.” ...

Incyte has delivered better returns than the broader market over the past year, and analysts view the stock’s outlook with measured optimism.

Studies of germline genetic testing programs provide a snapshot of challenges at academic and community practices at the NSGC annual meeting.

Falcon's Beyond Global, Inc. ("Falcon's Beyond", "Falcon's" or the "Company"), a visionary leader in innovative and immersive storytelling through its divisions Falcon's Creative Group ("FCG"), Falcon ...

Creative Media & Community Trust Corporation ("we", "our", "CMCT", or the "Company") today reported operating results for the three months ended September 30, 2025. Third Quarter 2025 Highlights Real ...

Lifeward Ltd., (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today ...